Article
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Breast cancer research and treatment - 1 Jul 2018
Munzone Elisabetta, Gray Kathryn P, Fumagalli Caterina, Guerini-Rocco Elena, Láng István, Ruhstaller Thomas, Gianni Lorenzo, Kammler Roswitha, Viale Giuseppe, Di Leo Angelo, Coates Alan S, Gelber Richard D, Regan Meredith M, Goldhirsch Aron, Barberis Massimo, Colleoni Marco
Abstract excerpt
PURPOSE: We investigated the occurrence and the prognostic and predictive relationship of a selected number of somatic mutations in triple-negative breast cancer (TNBC) patients having known clinical outcomes treated within the IBCSG Trial 22-00. METHODS: A matched case-control sampling selected patients enrolled in the IBCSG Trial 22-00 who had TNBC tumors, based on local assessment. Cases had invasive breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.